Walmart Inc. (WMT)

Key Updates

WMT has advanced 2.03% since the 16 September report, recovering from $107.50 to the current $109.68 — effectively erasing the mid-September pullback and returning to the level last seen on 14 September ($109.69). The move was concentrated in the most recent session (+2.08% 1-day), indicating a sharp bounce rather than a gradual grind higher. Despite the recovery, YTD performance remains negative at -1.55% and the 6-month return is -7.85%, confirming that the stock has not fully recovered from the post-Q2-earnings sell-off triggered by the 20 August report. No single news catalyst in the provided dataset explains the latest 1-day jump; the move appears technical/sentiment-driven following several weeks of consolidation between $104.87 and $109.69.

Current Trend

WMT is oscillating within a well-defined range established since the August earnings shock: a floor near $104.87 (1 September post-earnings trough) and a ceiling near $109.69 (pre-dip high, retested twice in September). The stock is currently trading at the upper boundary of this range. YTD the stock is down 1.55%, underperforming a market that has generally been resilient, while the 6-month decline of 7.85% reflects the structural impact of the Q2 miss on net income and EPS. A decisive break above $109.69 would be the first technical signal of trend reversal since the earnings-driven correction; failure to hold above this level would reinforce the range-bound, post-earnings consolidation pattern.

Investment Thesis

The core thesis remains bifurcated between near-term margin/comp-sales deceleration and long-term structural growth from higher-margin alternative revenue streams (advertising, marketplace, membership) and international expansion (China). Walmart's Q2 FY2027 results confirmed top-line resilience (+6% YoY revenue to $186.1bn) but also margin compression, with net income down 9% and diluted EPS down 9% YoY (SEC 10-Q). Morningstar's post-earnings valuation update reiterates a bearish stance, with an $81 fair value estimate and 2-star rating, implying the stock trades at a meaningful premium to intrinsic value despite raising estimates on advertising upside (Morningstar).

Thesis Status

The thesis is unchanged in substance but reinforced by new data points. The bull case is strengthened by continued momentum in high-margin, scalable businesses — advertising (tripled in four years, ~70% margins) (Morningstar) and China (20.7% comp growth, >50% online mix) (Fortune) — alongside new adjacent-market expansion into restaurant delivery (CNBC). However, the bear case is reinforced by confirmed margin pressure in the 10-Q and Morningstar's maintained overvaluation call. The price recovery to $109.68 narrows the near-term technical risk but does not resolve the fundamental valuation gap flagged by Morningstar ($81 fair value vs. current $109.68, implying ~26% downside on that model). Overall, the thesis remains valuation-constrained despite improving operational narratives in adjacent growth segments.

Key Drivers

• Q2 FY2027 results showed 6% revenue growth to $186.1bn but a 9% decline in net income and diluted EPS, reflecting margin compression (SEC EDGAR).
• US comparable sales growth slowed to 2.6%, the lowest since 2020, partly offset by a 7% tariff-refund-driven operating income boost (Morningstar).
• Walmart is redeploying ~$2.9bn in tariff refunds into price cuts on groceries and essentials, intensifying competitive pricing dynamics (Bloomberg).
• Resolution of the DOJ opioid lawsuit removes a multi-year legal overhang, with shares reacting positively (+0.5%) on the settlement news (CNBC).
• Expansion into restaurant delivery (Dunkin', Subway) leverages Walmart's logistics footprint (90% of Americans within 10 miles of a store) to boost basket size, with fast-delivery (under 30 minutes) up 48% YoY (CNBC), (Business Insider).

Technical Analysis

WMT is testing resistance near $109.69, the high established prior to the mid-September pullback, after rebounding from the $107.50 level recorded on 16 September and the broader post-earnings trough of $104.87 (1 September). The +2.08% single-day gain suggests renewed buying interest at range support, but the stock has not yet decisively broken above the $109.69 ceiling that has capped rallies twice in the past month. A sustained close above this level would be the first bullish technical signal since the August earnings-driven correction; a reversal back toward $107.50–$104.87 would confirm continuation of the range-bound consolidation. YTD (-1.55%) and 6-month (-7.85%) performance remain negative, underscoring that the broader trend since the Q2 report is still corrective despite short-term strength.

Bull Case

• Advertising business (Walmart Connect) has tripled in four years to $6.4bn in sales, operates at ~70% margins, and is projected to reach 41% of operating profit by FY2036 (Morningstar).
• Walmart China delivered 20.7% sales growth, nearly 8x the U.S. rate, with over 50% of sales now online, demonstrating successful omnichannel execution in a highly competitive market (Fortune).
• $2.9bn in tariff-refund-funded price cuts on groceries and essentials strengthen Walmart's competitive positioning and could support market share gains (Bloomberg).
• Restaurant delivery expansion (Dunkin', Subway) leverages existing grocery delivery infrastructure, with fast-delivery volumes up 48% YoY, adding a low-cost incremental revenue stream (CNBC).
• Settlement of the DOJ opioid lawsuit removes legal uncertainty tied to a multi-year federal case, with an immediate positive market reaction (CNBC).

Bear Case

• Q2 FY2027 net income fell 9% YoY and diluted EPS fell 9% YoY despite 6% revenue growth, indicating margin compression and rising costs (SEC EDGAR).
• US comparable sales growth decelerated to 2.6%, the lowest level since 2020, triggering a 9% single-day share price decline post-earnings (Morningstar).
• Morningstar maintains an $81 fair value estimate with a 2-star rating, implying the stock is trading at a significant premium (~26% at current price) to intrinsic value (Morningstar).
• Pharmacy pricing legislation created a 125-basis-point headwind to operating income, adding regulatory pressure on margins (Morningstar).
• Stock remains down 4.8% YTD as referenced in the advertising analysis, and the current dataset confirms a 6-month decline of 7.85%, signaling that recent short-term gains have not offset the broader post-earnings downtrend (Morningstar).